首页|期刊导航|中医肿瘤学杂志|荣血复正汤联合重组人血小板生成素对抗肿瘤治疗后血小板减少症患者临床疗效及对血清STAT3、vWF水平的影响

荣血复正汤联合重组人血小板生成素对抗肿瘤治疗后血小板减少症患者临床疗效及对血清STAT3、vWF水平的影响OA

Clinical Efficacy of Rongxue Fuzheng Decoction Combined with Recombinant Human Thrombopoietin in the Treatment of Thrombocytopenia After Anti-Tumor Therapy and Its Influences on the Serum Levels of STAT3 and vWF

中文摘要英文摘要

目的 探讨荣血复正汤与重组人血小板生成素(recombinant human thrombopoietin,rhTPO)联合对抗肿瘤治疗后患者并发血小板减少症(thrombocytopenia,TP)的效果.方法 回顾性选取河北省沧州中西医结合医院抗肿瘤治疗后TP患者86例,按治疗方案不同分为rhTPO组(采用rhTPO治疗,45例)和汤剂联合组(采用rhTPO联合荣血复正汤治疗,41例).比较两组总有效率、疾病改善情况、血常规指标、凝血功能指标及血清指标.结果 治疗后,汤剂联合组总有效率(93.33%)高于rhTPO组(78.05%)且(P<0.05);汤剂联合组中医证候积分、凝血酶原时间(prothrombin time,PT)、血管性血友病因子(von willebrand factor,vWF)水平、活化部分凝血活酶时间(activated partial thromboplastin time,APTT)均低于rhTPO组(P<0.05);汤剂联合组白细胞计数(white blood cell,WBC)、血红蛋白(hemoglobin,Hb)、信号转导和转录激活因子3(signal transducer and activator of transcription 3,STAT3)、纤维蛋白原(fibrinogen,FIB)水平、卡氏功能状态(Karnofsky performance status,KPS)评分、血小板计数(platelet count,PLT)均高于rhTPO组(P<0.05).结论 荣血复正汤联合rhTPO可有效改善抗肿瘤治疗后TP患者的凝血功能,促进外周血PLT提升,调节血清STAT3及vWF水平,且安全性良好.

Objective To explore the efficacy of Rongxue Fuzheng Decoction combined with recombinant human thrombopoietin(rhTPO)in the treatment of thrombocytopenia(TP)in patients after anti-tumor therapy.Methods A retrospective study was conducted on 86 patients with TP after anti-tumor therapy in Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine.Patients were divided into the rhTPO group(treated with rhTPO,45 cases)and the combination group(treated with rhTPO and Rongxue Fuzheng Decoction,41 cases)according to different treatment regimens.The total effective rate,disease improvement,blood routine indicators,coagulation function indicators,and serum indicators were compared.Results The total effective rate in the combination group was higher than that in the rhTPO group[(93.33%vs 78.05%,P<0.05].The traditional Chinese medicine syndrome scores,prothrombin time(PT),von willebrand factor(vWF)level,and activated partial thromboplastin time(APTT)in the combination group were lower than those in the rhTPO group(P<0.05).The levels of white blood cell count(WBC),hemoglobin(Hb),signal transducer and activator of transcription 3(STAT3),fibrinogen(FIB),platelet count(PLT),and Karnofsky performance status(KPS)score in the combination group were higher than those in the rhTPO group(P<0.05).Conclusion Rongxue Fuzheng Decoction combined with rhTPO can effectively improve the coagulation function of TP patients after anti-tumor treatment,promote the increase of peripheral blood PLT,regulate the levels of serum STAT3 and vWF,and has good safety.

任睿泽;刘祥;段腾;刘菊;蒋玥;史福敏;王露露

河北省沧州中西医结合医院乳腺外一科,河北 沧州 061000河北省沧州中西医结合医院放射物理治疗科,河北 沧州 061000河北省沧州中西医结合医院介入及乳腺肿瘤内科,河北 沧州 061000河北省沧州中西医结合医院介入及乳腺肿瘤内科,河北 沧州 061000河北省沧州中西医结合医院介入及乳腺肿瘤内科,河北 沧州 061000河北省沧州中西医结合医院(东院区)放化疗科,河北 沧州 061000河北省沧州中西医结合医院介入及乳腺肿瘤内科,河北 沧州 061000

医药卫生

肿瘤疾病血小板减少症中医重组人血小板生成素血常规

tumor diseasesthrombocytopeniatraditional Chinese medicinerecombinant human thrombopoietinblood routine

《中医肿瘤学杂志》 2026 (4)

94-100,7

2026年度中医药类科学研究课题计划项目(编号:2026158).

10.19811/j.cnki.ISSN2096-6628.2026.07.013

评论